Direkt zum Inhalt
Merck
  • Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant.

Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant.

Bioorganic & medicinal chemistry (2009-04-14)
Kristina Berggren, Björn Johansson, Tomas Fex, Jan Kihlberg, Lars Björck, Kristina Luthman
ZUSAMMENFASSUNG

Analogues of the irreversible protease inhibitors TPCK and TLCK have been synthesized and tested as inhibitors of the bacterial cysteine protease IdeS excreted by Streptococcuspyogenes. Eight compounds were identified as inhibitors of IdeS in an in vitro assay. The most potent compounds contained an aldehyde function, thus acting as efficient reversible inhibitors, nitrile and azide derivatives showed moderate activity.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
N-p-Tosyl-L-phenylalaninchlormethylketon, ≥97% (TLC), powder